Back To: Home : Featured Technology : Stem Cell

CLICK HERE FOR WHAT'S NEW IN:
 

California Stem Cell and ALS TDI extend stem cell therapy deal
March 2010
SHARING OPTIONS:

CAMBRIDGE, Mass.California Stem Cell Inc. (CSC) and ALS Therapy Development Institute (ALS TDI) announced in February an extension and expansion of their collaboration aimed at advancing a potential stem cell therapy for amyotrophic lateral sclerosis (ALS). Previous experiments conducted by the parties sought to understand how stem cells and their derivatives may be applied to treatment of ALS. In a new round of experiments, ALS TDI will use a CSC high-purity line of stem cells, called MotorGraft, to deliver gene expression modifying payloads to specific locations within the central nervous system. The initial phase of this new collaboration will confirm the expression of these genes in vivo. Once expression is confirmed, the collaborators will conduct several full-efficacy experiments to measure for any potential ameliorating disease.

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.